Cornelisse LN, Van der Harst JE, Lodder JC, Baarendse PJ, Timmerman AJ, Mansvelder HD, Spruijt BM, Brussaard AB. Reduced 5-HT 1A -and GABA B receptor function in dorsal raphé neurons upon chronic fluoxetine treatment of socially stressed rats. J Neurophysiol 98: 196 -204, 2007. First published April 25, 2007; doi:10.1152/jn.00109.2007. Autoinhibitory serotonin 1A receptors (5-HT 1A ) in dorsal raphé nucleus (DRN) have been implicated in chronic depression and in actions of selective serotonin reuptake inhibitors (SSRI). Due to experimental limitations, it was never studied at single-cell level whether changes in 5-HT 1A receptor functionality occur in depression and during SSRI treatment. Here we address this question in a social stress paradigm in rats that mimics anhedonia, a core symptom of depression. We used whole cell patch-clamp recordings of 5-HT-and baclophen-induced G-proteincoupled inwardly rectifying potassium (GIRK) currents as a measure of 5-HT 1A -and GABA B receptor functionality. 5-HT 1A -and GABA B receptor-mediated GIRK-currents were not affected in socially stressed rats, suggesting that there was no abnormal (auto)inhibition in the DRN on social stress. However, chronic fluoxetine treatment of socially stressed rats restored anticipatory behavior and reduced the responsiveness of 5-HT 1A receptor-mediated GIRK currents. Because GABA B receptor-induced GIRK responses were also suppressed, fluoxetine does not appear to desensitize 5-HT 1A receptors but rather one of the downstream components shared with GABA B receptors. This fluoxetine effect on GIRK currents was also present in healthy animals and was independent of the animal's "depressed" state. Thus our data show that symptoms of depression after social stress are not paralleled by changes in 5-HT 1A receptor signaling in DRN neurons, but SSRI treatment can alleviate these behavioral symptoms while acting strongly on the 5-HT 1A receptor signaling pathway. 1995;Pejchal et al. 2002;Shen et al. 2002;Subhash et al. 2000). Although it remains unclear by which mechanism SSRIs exert their antidepressant action, there is a clear relation between reduced 5-HT1 A receptor function and increased 5-HT levels in DRN innervated forebrain areas after SSRI treatment in rodents. If SSRIs are acutely applied, locally enhanced 5-HT levels in the DRN inhibit serotonernergic neurons through activation of the 5-HT1 A autoreceptor. This results in decreased 5-HT release in the projection areas (Artigas et al. 1996b). However, after chronic SSRI treatment, 5-HT1 A receptors are desensitized, and firing of DRN cells is restored resulting in increased 5-HT levels in the frontal cortex (Artigas et al. 1996b;Bel and Artigas 1993). Co-application of 5-HT1 A receptor antagonists appears to prevent the initial decrease of 5-HT release in the forebrain during SSRI treatment and may accelerate antidepressant responses in patients (Artigas et al. 1996b;Blier et al. 1998).These studies suggest a role for DRN 5-HT1 A autoreceptors in etiology of depression as well as in ...